Article thumbnail

Associating GWAS Information with the Notch Signaling Pathway Using Transcription Profiling

By Chindo Hicks, Antonio Pannuti and Lucio Miele

Abstract

Genome-wide association studies (GWAS) have identified SNPs associated with breast cancer. However, they offer limited insights about the biological mechanisms by which SNPs confer risk. We investigated the association of GWAS information with a major oncogenic pathway in breast cancer, the Notch signaling pathway. We first identified 385 SNPs and 150 genes associated with risk for breast cancer by mining data from 41 GWAS. We then investigated their expression, along with 32 genes involved in the Notch signaling pathway using two publicly available gene expression data sets from the Caucasian (42 cases and 143 controls) and Asian (43 cases and 43 controls) populations. Pathway prediction and network modeling confirmed that Notch receptors and genes involved in the Notch signaling pathway interact with genes containing SNPs associated with risk for breast cancer. Additionally, we identified other SNP-associated biological pathways relevant to breast cancer, including the P53, apoptosis and MAP kinase pathways

Topics: Original Research
Publisher: Libertas Academica
OAI identifier: oai:pubmedcentral.nih.gov:3091413
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
  2. (1998). A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev.
  3. (2006). Aberrant activation of Notch signaling in human breast cancer. Cancer Res.
  4. (2002). Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med.
  5. (2006). c-Myc is an important direct target of
  6. Common variants on Chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.
  7. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the breast cancer association consortium.
  8. (2008). Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations. Hum Mol Genet.
  9. Controlling the false discovery rat: a practical and powerful approach to multiple testing.
  10. (2008). Crosstalk between Notch and estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res.
  11. (2008). Di Fiore PP. NUMB controls p53 tumor suppressor activity. Nature.
  12. (1993). Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch. Nature.
  13. (2007). Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet.
  14. (2008). ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene.
  15. Facts and Figures 2009–2010.
  16. Gene and pathway-based second-wave analysis of genome-wide association studies.
  17. Gene expression patterns distinguish breast carcinomas from normal breast tissues: The Malaysia context. Pathology-Res Pract.
  18. (2006). GenePattern 2.0. Nature Genetics.
  19. Genome-wide association study identifies five new breast cancer susceptibility loci.
  20. Genome-wide association study identifies novel breast cancer susceptibility loci.
  21. (2005). Genome-wide associations of gene expression variation in Humans. PLoS Genetics.
  22. (2009). Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett.
  23. (2004). Glycogen synthase kinase-3 in insulin and Wnt signaling: a double-edged sword? Biochem Soc Trans.
  24. (2009). GWS meets microarray: Are the results of genome-wide association studies and gene expression profiling consistent? Prostate cancer as an example. PLoS One.
  25. (2005). High-level co-expression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res.
  26. (2007). High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod Pathol.
  27. (2009). Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells. Int J Radiat Oncol Biol Phys.
  28. (2010). Ku is a 5’-dRP/AP lyase that excises nucleotide damage near broken ends. Nature.
  29. (2004). Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol.
  30. Microarray Analysis Suite 5.0, Affymetrix Inc.
  31. (2008). Molecular separation of two signaling pathways for the receptor, Notch. Dev Biol.
  32. (2007). Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med.
  33. (1993). Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell.
  34. (1997). MutS homologs in mammalian cells. Curr Opin Genet Dev.
  35. (2010). New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res.
  36. (2007). Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation. EMBO J.
  37. (2010). Notch promotes radioresistance of glioma stem cells. Stem Cells.
  38. (2006). Notch signaling in breast cancer and tumor angiogenesis: Cross-talk and therapeutic potentials.
  39. (2002). Notch signaling in cancer. Cancer Biol Therap.
  40. (2006). Notch signaling in cancer. Curr Mol Med.
  41. (2010). Notch-1 activates estrogen receptor-alphadependent transcription via IKKalpha in breast cancer cells. Oncogene.
  42. Notch2 breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations. Molecular Cancer.
  43. (2008). Opposite effects of Notch-1 and Notch-2 on mesothelioma cell survival under hypoxia are exerted through the Akt pathway. Cancer Res.
  44. (2003). Osprey: a network visualization system. BMC Genome Biology.
  45. (2007). PARtitioning numb. EMBO Rep.
  46. (2010). Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res.
  47. (2009). Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS One.
  48. Pathway analysis of seven common diseases assessed by genome-wide association.
  49. (2009). Pathway and network analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet.
  50. (2009). Pathway based analysis of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission. Hum Genet.
  51. Pathway-based approaches to analysis of genomewide association studies.
  52. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.
  53. Proliferative genes dominate malignancy-risk gene signature in historically-normal breast cancer. Breast Cancer Res Treat.
  54. (2010). Radiation resistance of cancer stem cells: the 4 R’s of radiobiology revisited. Stem Cells.
  55. (2008). Rational targeting of Notch signaling in breast cancer. Expert Rev Anticancer Ther.
  56. Recent insights into the role Notch signaling in tumorigenesis.
  57. (2010). Selective targeting of radiation-resistant tumor-initiating cells.
  58. (2005). Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression. Cancer Res.
  59. (2010). Targeting Notch to target cancer stem cells. Clin Cancer Res.
  60. (2007). Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med.
  61. (2009). The canonical Notch signaling pathway: unfolding the activation mechanism. Cell.
  62. (2006). The CHEK2 gene and inherited breast cancer susceptibility. Oncogene.
  63. The distribution of the partial correlation coefficient.
  64. (2004). The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumor clinicopathological parameters in human breast cancer. Int J Mol Med.
  65. The response of CD24(-/low)/ CD44+ breast cancer-initiating cells to radiation.
  66. (2004). The Werner syndrome protein at the crossroads of DNA repair and apoptosis. Mech Aging Dev.
  67. (2008). WRN is required for ATM activation and the S-phase checkpoint in response to interstrand cross-link-induced DNA double-strand breaks. Mol Biol Cell.